| Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI B Vasey, M Nagendran, B Campbell, DA Clifton, GS Collins, S Denaxas, ... bmj 377, 2022 | 333 | 2022 |
| Big data and machine learning in radiation oncology: state of the art and future prospects JE Bibault, P Giraud, A Burgun Cancer letters 382 (1), 110-117, 2016 | 329 | 2016 |
| Deep learning and radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer JE Bibault, P Giraud, M Housset, C Durdux, J Taieb, A Berger, R Coriat, ... Scientific reports 8 (1), 12611, 2018 | 212 | 2018 |
| When chatbots meet patients: one-year prospective study of conversations between patients with breast cancer and a chatbot B Chaix, JE Bibault, A Pienkowski, G Delamon, A Guillemassé, P Nectoux, ... JMIR cancer 5 (1), e12856, 2019 | 190 | 2019 |
| A chatbot versus physicians to provide information for patients with breast cancer: blind, randomized controlled noninferiority trial JE Bibault, B Chaix, A Guillemassé, S Cousin, A Escande, M Perrin, ... Journal of medical Internet research 21 (11), e15787, 2019 | 144 | 2019 |
| Deep learning: a review for the radiation oncologist L Boldrini, JE Bibault, C Masciocchi, Y Shen, MI Bittner Frontiers in oncology 9, 977, 2019 | 144 | 2019 |
| DECIDE-AI: new reporting guidelines to bridge the development-to-implementation gap in clinical artificial intelligence Nature Medicine 27 (2), 186-187, 2021 | 131 | 2021 |
| Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity JE Bibault, S Dewas, C Vautravers-Dewas, A Hollebecque, H Jarraya, ... PloS one 8 (10), e77472, 2013 | 126 | 2013 |
| Radiomics and machine learning for radiotherapy in head and neck cancers P Giraud, P Giraud, A Gasnier, R El Ayachy, S Kreps, JP Foy, C Durdux, ... Frontiers in oncology 9, 174, 2019 | 107 | 2019 |
| Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer JE Bibault, B Prevost, E Dansin, X Mirabel, T Lacornerie, E Lartigau Radiation oncology 7, 1-7, 2012 | 100 | 2012 |
| Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy S Dewas, JE Bibault, X Mirabel, I Fumagalli, A Kramar, H Jarraya, ... Radiation Oncology 7, 1-9, 2012 | 92 | 2012 |
| Healthcare ex Machina: Are conversational agents ready for prime time in oncology? JE Bibault, B Chaix, P Nectoux, A Pienkowski, A Guillemasé, B Brouard Clinical and translational radiation oncology 16, 55-59, 2019 | 90 | 2019 |
| Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations B Chaix, G Delamon, A Guillemassé, B Brouard, JE Bibault General psychiatry 33 (6), 2020 | 81 | 2020 |
| Radiomics: A primer for the radiation oncologist JE Bibault, L Xing, P Giraud, R El Ayachy, N Giraud, P Decazes, A Burgun Cancer/Radiothérapie 24 (5), 403-410, 2020 | 73 | 2020 |
| Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results S Dewas, JE Bibault, X Mirabel, P Nickers, B Castelain, T Lacornerie, ... Radiation Oncology 6, 1-8, 2011 | 68 | 2011 |
| Adjuvant radiation therapy in metastatic lymph nodes from melanoma JE Bibault, S Dewas, X Mirabel, L Mortier, N Penel, L Vanseymortier, ... Radiation Oncology 6, 1-6, 2011 | 67 | 2011 |
| Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review JE Bibault, I Fumagalli, C Ferté, C Chargari, JC Soria, E Deutsch Cancer and Metastasis Reviews 32, 479-492, 2013 | 64 | 2013 |
| Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia JE Bibault, M Figeac, N Hélevaut, C Rodriguez, S Quief, S Sebda, ... Oncotarget 6 (26), 22812, 2015 | 63 | 2015 |
| A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases I Fumagalli, JE Bibault, S Dewas, A Kramar, X Mirabel, B Prevost, ... Radiation oncology 7, 1-8, 2012 | 61 | 2012 |
| IGF-1R targeting increases the antitumor effects of DNA-damaging agents in SCLC model: an opportunity to increase the efficacy of standard therapy C Ferté, Y Loriot, C Clémenson, F Commo, A Gombos, JE Bibault, ... Molecular cancer therapeutics 12 (7), 1213-1222, 2013 | 55 | 2013 |
Philippe GiraudProfesseur des Universités - Praticien Hospitalier Hôpital européen Georges Pompidou, Paris, FranceVerified email at aphp.fr
